The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Đình Thiểm, Vũ; C. Lin, Feng‐Ying; Gia Canh, Do; Hồng Sơn, Nguyễn; Đức Anh, Đặng; Duc Mao, Nguyen; Chu, Chiayung; Hunt, Steven; B. Robbins, John; Schneerson, Rachel; C. Szu, Shousun

doi:10.1128/cvi.00532-10

Public

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Published in Clinical and Vaccine Immunology • Mar 17, 2011

Authors:

Vũ Đình Thiểm

Feng‐Ying C. Lin

Do Gia Canh

Abstract

Typhoid fever remains a serious problem in developing countries. Current vaccines are licensed for individuals who are 5 years old or older. A conjugate of the capsular polysaccharide (CP) of Salmonella enterica serovar Typhi (Vi) bound to recombinant exoprotein A of Pseudomonas aeruginosa (Vi-rEPA)...

Subject

Typhoid fever

Conjugate

Conjugate vaccine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!